|
Spin Control: SMBs that develop software for their own needs know potential markets from the inside, but there's more to consider for a successful spin-off
For almost a year, Owen Barrett and Craig Robertson searched to no avail for an affordable software tool to help manage and integrate the business processes of their small company.
Team NEO hires executive to recruit Innovation Center businesses
Team NEO and the Cleveland Clinic are joining forces to attract bioscience and medical-device companies for the yet-to-be-built Global Cardiovascular Innovation Center on the hospital system's main campus.
Cleveland cardiologists discover clue in good-cholesterol puzzle
A team of cardiologists from Cleveland discovered an important clue as to why the protein that ferries so-called good cholesterol in and out of cells doesn't always leave with its cargo intact.
Brain surgery changes broker's outlook on advice
Forty-one years after he enlisted in the Army during the Vietnam era, Hunter Smith sports the same haircut — this time after surgery to implant electrodes and a brain pacemaker that have alleviated tremors of Parkinson’s disease that plagued the 61-year-old Charleston stockbroker.
Clinic NanoMed program gets $1 million grant
The Cleveland Clinic’s NanoMedicine Program has received a $1 million grant from a nanotechnology company to create and test pharmaceutical compounds to treat degenerative diseases and some cancers.
Cleveland Clinic part of new cardiac surgery clinical trials network
Heart bypasses are on the decline, but the lucrative and evolving field of cardiac surgery is busier than ever, prompting the government to create an unusual clinical trials network that will look at which novel surgical techniques work best in which patients.
AcelleRX Therapeutics receives initial financing; company preparing for phase 1 clinical trial of chronic heart failure treatment
AcelleRX Therapeutics, Inc., a Cleveland Clinic start up company, that develops regenerative medicine technologies for treatment of cardiovascular disease and other ischemic disorders, today announced the company received its first round of private funding.
Third Frontier program invests about $300 million in Northeast Ohio Granting
The Third Frontier Project is beginning to reap big returns in Northeast Ohio.
Quantum dots outline brain tumors for surgical removal
Although surgical removal of a tumor can be the most effective way of treating brain cancer, neurosurgeons are often faced with the dilemma of determining the exact border between a tumor and the healthy tissue that surrounds it.
Intelect Medical wins $7 million from device makers
Intelect Medical Inc., the Cleveland Clinic spinoff that is developing systems to modulate brain activity, has closed a financing round with $7 million from Boston Scientific Corp. and Greatbatch Inc.
Electrical pulses 'rouse' patient: Deep brain stimulation with electrical pulses may offer hope for patients trapped in a minimally conscious state
Treatment of a 38-year-old man with a severe brain injury enabled him to use words and gestures, chew and swallow and drink from a cup, say US doctors.
Cleveland case study: Going from a tech transfer laggard to the top 10
Cleveland is becoming a hotbed of successful research commercialization, and tech transfer professionals are getting the lion's share of the credit.
Bioscience bosses break bread with Hungary: Proficiency in research, commercialization deficiency make country ripe for partnership
Northeast Ohio's bioscience community is expanding its circle of overseas friends.
Cleveland BioLabs compound could be breakthrough
A compound being commercialized by Cleveland BioLabs Inc. helped regenerate bone marrow stem cells in mice that received transplants.
The TIME 100: Steven Nissen
In some ways, Steve Nissen's undergraduate years at the University of Michigan - which included crusading against the Vietnam War - were the toughest period of his life.
Region on par with peers for invention disclosures
Cleveland might not have the warm weather of Research Triangle, North Carolina, or an Ivy League university like Boston, but its doctors and professors are keeping up with their peers when it comes to inventions.
Clinic doctor on prestigious Time 100 list: Nissen one of the most influential people in world
He is a former war protester who became chief of cardiology at one of the world's premier hospitals.
From ideas to inventions: Medical Device Solutions turns Clinic docs', researchers' dreams into concrete designs
Brian Davis jokes that his feet might end up beating a path between the Cleveland Clinic and its technology commercialization office.
Clinic's CCF Innovations licensing revenues triple to reach $9.9M
One-time deals helped the Cleveland Clinic's technology commercialization arm triple its licensing income in 2005, but the spike in revenue won't be a one-time increase over levels from previous years, according to the organization's director.
Cleveland BioLabs raises $30 million
Cleveland BioLabs Inc. has raised $30 million from accredited investors in a private placement of 4.3 million shares of Series B convertible preferred stock.
Cleveland Clinic awarded four new patents for new medical devices
Cleveland Clinic recently received four U.S. patents for innovations in ophthalmology, cardiology and for developing a support pad for surgical patients.
Technology to go: The CCF Innovations unit at the Cleveland Clinic turns medical ideas into businesses
Several years ago, Dr. Mark Penn and his colleagues at the Cleveland Clinic were trying to figure out why certain stem cells target the heart.
Grant
happy : Hearts, minds - even urban neighborhoods - will
gain from $113 million in Third Frontier money flowing
to NE Ohio
A little over a year ago, voters approved pouring $500
million of state money into high-tech projects, betting
it would create jobs here and keep - and lure - coveted
scientists and promising start-up companies.
$60
Million in State Funding to Develop Global Cardiovascular
Innovation Center
Cleveland Clinic, in collaboration Fairfax Renaissance
Development Corporation (FRDC) and more than 20 biomedical
and academic institutions, will receive $60 million
from the State of Ohio to develop a Global Cardiovascular
Innovation Center (GCIC).
State
money for technology, jobs NE Ohio gets a high-tech
boost State grants to create jobs here Third Frontier
cash to add jobs: Clinic-led effort is one of 6 in region
sharing $113 million $113 million in Third Frontier
cash to go to six projects The state will pour more than $113 million
in Third Frontier money into Northeast Ohio, including
$60 million for a Cleveland Clinic-led effort that could
create hundreds of jobs and establish the city as a
hub of biotech innovation.
Scientists
harness mysteries of the brain
A young woman, confined to a wheelchair, is told to
think about moving another wheelchair in front of her,
first to the left and then forward.
Neurotechnology
development treads tougher VC funding path
As the Cleveland Clinic Innovation Summit
began to wind down last week, the promise of the neuroscience
field was tempered with the realization that someone
has to pay to develop all of these future and very enticing
technologies.
Cleveland
Clinic Unveils Top 10 Medical Innovations for '07
Last week, Cleveland Clinic announced its
first-ever Top 10 Medical Innovations list, highlighting
technologies that will likely have a big impact on healthcare
in 2007.
Clinic
unveils 'Top Ten' list of medical innovations for 2007As an interesting addition this year
to its Innovation Summit, the Cleveland Clinic unveiled
the first of what promises to be an annual “Top
Ten” list of what it predicts as the most promising
medical innovations in the coming year.
Real
surgeries, amazing results
"This is really neat stuff you're about
to see," Cleveland Clinic Wooster gastroenterologist
James Murphy told a group of students privileged to
observe live surgeries performed by internationally
recognized Cleveland Clinic surgeons.
As
in cardiology, implantable' is wave of neuromodulation
future
Within the promising early-stage realm of neuroscience,
one area of particular interest for physicians, patients
and investors is undoubtedly implantable neuromodulation
devices.
Cleve
BioLabs in defense contract talks
Cleveland BioLabs Inc., a drug discovery and development
company, has begun contract negotiations with the Defense
Threat Reduction Agency to complete development of radiation
protectors for the U.S. Department of Defense.
Clinic
targets changing medicine via new Neurological Institute
As the Cleveland Clinic Innovation Summit got underway
this week, this top-tier medical and research facility
wasted no time in getting to the topic that was to be
a primary one at this fourth annual event — the
field of neuroscience.
Cooperation
a must to restrain health costs
The government and public and private entities will
need to work together to reduce skyrocketing health
care costs and the number of uninsured Americans.
Ten
emerging technologies will shape healthcare next year,
hospital predicts
Cleveland Clinic today announced its first-ever Top
10 Medical Innovations list, highlighting technologies
which will likely have a big impact on healthcare in
2007.
Cancer
vaccines top innovation list at Clinic
Cancer vaccines will have the biggest impact on health
care in 2007, a panel of Cleveland Clinic physicians
and scientists predicts.
Meeting
set to spotlight the embryonic neurology field
According to Chris Coburn, executive director of CCF
Innovations— the technology transfer and commercialization
arm of the Cleveland Clinic— this year’s
Innovation Summit, which is focusing on the neurology
market, was not as easy a sell as the past three conferences
have been.
Conference
blends business, medicine
The Cleveland Clinic is convening more than 800 medical
and business professionals on its campus today to talk
about developing, investing in and paying for medical
devices and therapies related to the brain.
Implant
gives brain-injured patient, researchers hope A constant trickle of electricity into the
severely damaged and semiconscious brain of a 38-year-old
assault victim has made him significantly more aware
and responsive, a Cleveland Clinic neurosurgeon and
his colleagues reported Sunday.
State
doesn't keep the right graduates: Science PhDs tend
to go elsewhere
The human heart sparks electricity with each beat. When
it skips and its rhythm breaks, life turns fragile.
Clinic,
Case, KSU vie for pot of tech grant money
The Cleveland Clinic, Case Western Reserve University
and Kent State University all are competing for a lucrative
but limited supply of dollars from the state’s
Third Frontier technology development program.
BioLabs
gets $750k for research
Cleveland BioLabs Inc. has received a $750,000 small
business research grant from the National Institutes
of Health to advance research into substances that protect
healthy cells against exposure to radiation.
BioLabs
completes trial
Cleveland BioLabs Inc. (Nasdaq: CBLI) has announced
the results of clinical trials of a radioprotective
drug on monkeys — something it said it hopes will
help to secure U.S. Food and Drug Administration approval
of a drug that protect humans against radiation.
Cleveland
BioLabs takes leap into choppy waters for IPOs
If recent months are any indication, the stock of Cleveland
Clinic spinoff Cleveland BioLabs Inc. could be in for
a bumpy ride after going public last week.
Cleveland
Clinic spinoff goes public: BioLabs will use money for
drug development
Cleveland BioLabs Inc., a spinoff of the Cleveland Clinic
that is working on anti-radiation and cancer drugs,
went public Thursday. The company expects to net $8.5
million from its public offering of 1.7 million shares.
Clinic
licenses stem cell therapies
The Cleveland Clinic and its technology transfer unit,
CCF Innovations, have licensed five pending patents
on stem cell therapies for repairing scarred hearts
to Bioheart Inc. of Sunrise, Fla.
Cleve.
Biolabs plans $14M IPO
Cleveland Biolabs Inc., a development-stage biodefense
and cancer treatment pharmaceutical products company,
hopes to raise nearly $14 million in a public stock
offering. |
